Preclinical effects: learned behavior.
A review of the previous Marihuana and Health Reports (1971-1975) reveals that an extensive array of experimental procedures and contexts have been used to study the effects of cannabinoids on the performance of learned behavior in animals. These preclinical behavioral experiments have provided a framework for, and guided the design of, subsequent human experimentation. Compared to previous years, only a few experiments pertaining to cannabinoids and learned behavior have appeared during the past two years. By and large these more recent experiments confirm previous findings; no particularly novel procedures have been explored nor have there been dramatically unpredictable results. In part, the decrease in activity in cannabinoid preclinical animal research on learned behavior indicates an increase in human cannabinoid-learning investigations. Several detailed taxonomies of learned behavior are possible. However, for the purposes of the present report, learned behaviors will be categorized into those involving: avoidance learning and aversive control; reinforcement schedules and maze learning; and discrimination learning.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002186:Cannabinoids / Q000494:pharmacology*; D002187:Cannabinol / Q000494:pharmacology; D003216:Conditioning, Operant / Q000187:drug effects*; D004193:Discrimination Learning / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000494:pharmacology; D004361:Drug Tolerance; D011930:Reaction Time / Q000187:drug effects; D012055:Reinforcement Schedule
D002186:Cannabinoids; D013759:Dronabinol; D002187:Cannabinol